Terms: = Prostate cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Diagnosis
32 results:
1. Gelatinous Pleural Effusion: A Diagnostic Challenge for Pleural Mesothelioma in an 80-Year-Old Man.
Ibnian AM; Khan OU; Chan R; Bangalore Lakshminarayana U; Kiran F; Abed S; Abbas R; Amir A; Al-Kofahi NK
Am J Case Rep; 2023 Oct; 24():e941263. PubMed ID: 37793939
[TBL] [Abstract] [Full Text] [Related]
2. Primary prostate cancer synchronous with renal cell carcinoma: clinical experience and literature review.
Li ZY; Ying CC; Wan ZH; Wang ZS; Li GH; Chen L; Guo YL
Rom J Morphol Embryol; 2020; 61(2):555-561. PubMed ID: 33544809
[TBL] [Abstract] [Full Text] [Related]
3. Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups.
Alshaker H; Mills R; Hunter E; Salter M; Ramadass A; Skinner BM; Westra W; Green J; Akoulitchev A; Winkler M; Pchejetski D
J Transl Med; 2021 Jan; 19(1):46. PubMed ID: 33509203
[TBL] [Abstract] [Full Text] [Related]
4. Recent advances in nanomaterials for colorimetric cancer detection.
Wang H; Wu T; Li M; Tao Y
J Mater Chem B; 2021 Jan; 9(4):921-938. PubMed ID: 33367450
[TBL] [Abstract] [Full Text] [Related]
5. Nanotechnology in ovarian cancer: diagnosis and treatment.
Barani M; Bilal M; Sabir F; Rahdar A; Kyzas GZ
Life Sci; 2021 Feb; 266():118914. PubMed ID: 33340527
[TBL] [Abstract] [Full Text] [Related]
6. Malignant solitary fibrous tumour of the prostate: four cases emphasising significant histological and immunophenotypical overlap with sarcomatoid carcinoma.
Bakhshwin A; Berry RS; Cox RM; Li R; Reynolds JP; Rubin BP; McKenney JK
Pathology; 2020 Oct; 52(6):643-648. PubMed ID: 32758370
[TBL] [Abstract] [Full Text] [Related]
7. Quantitative Analysis of Ultrasound Tissue Diffusion Elastography in The diagnosis of Benign and Malignant prostate Lesions.
Guo J; Liang L; Zhou N; Li DY
Urol J; 2019 Aug; 16(4):347-351. PubMed ID: 30882174
[TBL] [Abstract] [Full Text] [Related]
8. Construction of a set of novel and robust gene expression signatures predicting prostate cancer recurrence.
Jiang Y; Mei W; Gu Y; Lin X; He L; Zeng H; Wei F; Wan X; Yang H; Major P; Tang D
Mol Oncol; 2018 Sep; 12(9):1559-1578. PubMed ID: 30024105
[TBL] [Abstract] [Full Text] [Related]
9. Ultrasensitive detection of mucin 1 biomarker by immuno-loop-mediated isothermal amplification.
Cao H; Fang X; Li H; Li H; Kong J
Talanta; 2017 Mar; 164():588-592. PubMed ID: 28107977
[TBL] [Abstract] [Full Text] [Related]
10. prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract] [Full Text] [Related]
11. Quantitative ultrasound at the hand phalanges in patients with bisphosphonate-related osteonecrosis of the jaws.
Motta AC; de Macedo LD; Santos GG; Guerreiro CT; Ferrari T; de Oliveira TF; Santos PS; de Oliveira-Santos C; Ricz HM; Xavier SP; Iannetta O
Braz Oral Res; 2015; 29(1):S1806-83242015000100301. PubMed ID: 26892357
[TBL] [Abstract] [Full Text] [Related]
12. Testosterone Replacement Therapy and Mortality in Older Men.
Hackett GI
Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385
[TBL] [Abstract] [Full Text] [Related]
13. Benign notochordal cell tumor: a retrospective study of 11 cases with 13 vertebra bodies.
Ma X; Xia C; Liu D; Liu H; Wang C; Yu H
Int J Clin Exp Pathol; 2014; 7(7):3548-54. PubMed ID: 25120733
[TBL] [Abstract] [Full Text] [Related]
14. A three-protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease.
Severi G; FitzGerald LM; Muller DC; Pedersen J; Longano A; Southey MC; Hopper JL; English DR; Giles GG; Mills J
Cancer Med; 2014 Oct; 3(5):1266-74. PubMed ID: 24909936
[TBL] [Abstract] [Full Text] [Related]
15. Prostatic stromal sarcoma with neuroectodermal differentiation.
Yamazaki H; Ohyama T; Tsuboi T; Taoka Y; Kohguchi D; Iguchi H; Ao T
Diagn Pathol; 2012 Dec; 7():173. PubMed ID: 23217062
[TBL] [Abstract] [Full Text] [Related]
16. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.
Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F
Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265
[TBL] [Abstract] [Full Text] [Related]
17. Molecular evolution of specific human antibody against muc1 mucin results in improved recognition of the antigen on tumor cells.
Persson J; Bäckström M; Johansson H; Jirström K; Hansson GC; Ohlin M
Tumour Biol; 2009; 30(4):221-31. PubMed ID: 19776674
[TBL] [Abstract] [Full Text] [Related]
18. Atypical ductal adenocarcinoma of the prostate with endometrioid immunohistological features.
Lucan M; Vasiliu V; Iacob G; Lucan V
Chirurgia (Bucur); 2009; 104(3):355-8. PubMed ID: 19601472
[TBL] [Abstract] [Full Text] [Related]
19. Characterization of muc1 glycoprotein on prostate cancer for selection of targeting molecules.
Burke PA; Gregg JP; Bakhtiar B; Beckett LA; Denardo GL; Albrecht H; De Vere White RW; De Nardo SJ
Int J Oncol; 2006 Jul; 29(1):49-55. PubMed ID: 16773184
[TBL] [Abstract] [Full Text] [Related]
20. Aberrant expression of transmembrane mucins, muc1 and MUC4, in human prostate carcinomas.
Singh AP; Chauhan SC; Bafna S; Johansson SL; Smith LM; Moniaux N; Lin MF; Batra SK
Prostate; 2006 Mar; 66(4):421-9. PubMed ID: 16302265
[TBL] [Abstract] [Full Text] [Related]
[Next]
